Company News
Bristol-Myers Squibb to acquire Georgia drug developer
1/9/2012
The biopharmaceutical maker Bristol-Myers Squibb Co. has reached an agreement to acquire clinical-stage biopharmaceutical company Inhibitex, Inc.
CNY Business Journal
Return to Previous Page